Average optical densities were evaluated only in patients showing immunopositivity. To look at the vasculature in our samples, we immunostained them with anti-CD34 mouse using IHC method. CD34 consistently showed immunoreactivity in the plasma membrane of Selleck Caspase Inhibitor VI endothelial cells in all prostates specimens (Figure 1E, I and 1M). Measuring the optical density of CD34 immunostaining, we found that there is a significant difference in vasculature density between normal, hyperplasia and tumors in our collection Mdivi1 mouse (Figure 2C). Interestingly, similar

to PSMA, CD34 staining was found more abundant in PC specimens (12.08 ± 0.29), compared with NP and BPH (p < 0.0001). Vessel density was higher in BPH compared to NP samples (8 ± 0.11 and 2.34 ± 0.15, respectively) (p < 0.0001) (Figure 2C). To study the relationship between PSMA and PSA expression and microvessel density in BPH and PC samples,

we divided BPH and PC samples into 3 subgroups. The first group has a CD34 OD values between 2.34 and 8, the second group has a CD34 OD values between 8 and 12.08 and the third group has a CD34 OD value superior to 12.08 (Figure 2C and Figure 3). Figure 3 Association between immunostaining intensity of CD34, PSMA and PSA expression among tissue CD34 levels in benign prostatic hyperplasia (BPH) (A) and prostate cancer (PC) patients (B). Values were expressed as mean ± SEM. Average optical densities were evaluated only in patients showing immunopositivity. Statistical analysis refers to each antibody separately. Selleck Vemurafenib Values denoted by different superscripts are significantly different from each other. Those values sharing the same superscript are not statistically different from each other. Statistical analysis refers to each antibody separately. Significance was determined at p≤0. 05; 2.34: Mean O.D of CD34 value in NP; 8: Mean O.D of CD34 value

in BPH and 12.08: Mean O.D of CD34 value in PC patients. In BPH samples, no difference neither in PSA nor PSMA expression was found in all 3 subgroups Racecadotril (Figure 3A). Importantly, depending on the degree of vascularisation, we found an inverse relation between angiogenesis and PSA in PC patients. Unlike PSA, the highest intratumoral angiogenesis is accompanied by high PSMA expression in prostate cancer cells (Figure 3B). To study the distinct pattern of proteins tumour profiles produced by prostate epithelial cells we established different prostate-associated antigens profiles depending on positive immunoreactions to PSA and PSMA in NP, BPH and PC samples. We obtained a negative group for PSA and/or PSMA in each prostate type. The distribution of this group was as followed: 2 in NP, 13 in BPH and 11 in PC patients.